Distribution of human papillomavirus types in anogenital warts of men

被引:53
作者
Chan, Paul K. S. [1 ]
Luk, Alfred C. S. [1 ]
Luk, Tommy N. M. [2 ,3 ]
Lee, Kwong-Fai [3 ]
Cheung, Jo L. K. [1 ]
Ho, King-Man [3 ]
Lo, Kuen-Kong [3 ]
机构
[1] Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dermatol Res Ctr, Shatin, Hong Kong, Peoples R China
[3] Ctr Hlth Protect, Social Hyg Serv, Dept Hlth, Hong Kong, Hong Kong, Peoples R China
关键词
Human papillomavirus; Genotype; Anogenital wart; Male; Hong Kong; Vaccine; Condylomata accuminata; GRADE CERVICAL LESIONS; QUADRIVALENT VACCINE; PARTICLE VACCINE; CHINESE WOMEN; HPV INFECTION; CANCER; PREVALENCE; METAANALYSIS; AMPLIFICATION; EPIDEMIOLOGY;
D O I
10.1016/j.jcv.2008.11.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: A wide spectrum of human papillomavirus (HPV) types can infect the male genitalia. An HPV vaccine covering HPV6 and 11 is now available. Detailed data on the distribution of these two types in anogenital warts is needed to assess the potential benefits of the vaccine. Study design: Anogenital wart specimens collected from 130 Chinese men were examined for HPV-type distribution by a method that covers a broad spectrum of high- and low-risk HPVs, and able to reveal multiple types from a single specimen. Results: Forty-four (33.8%) of the 130 specimens had a coinfection with multiple HPV types. In 63.1% of cases, only HPV6 and/or HPV11 were/was found. In 26.2% of cases, HPV6 and/or HPV11 were/was found together with one or more other HPV types. In 10.8% of specimens, only non-6/11 HPV types were found. HPV16 and/or 18 were/was found in 12 (9.2%) specimens, with majority (8/12,66.7%) of which existed as coinfections with HPV6/11. Other HPV types found included HPV39,51, 52, 55, 59, 61, 62, 68, 58, 72, 81, 83, 84 and CP6108. Conclusions: A substantial proportion of HPV6/11-positive male anogenital warts are coinfected with other HPV types. The efficacy of HPV6/11 vaccine for preventing these lesions needs to be defined before the benefits of vaccinating men can be precisely assessed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:111 / 114
页数:4
相关论文
共 29 条
  • [11] Prevalence of HPV infection among men: A systematic review of the literature
    Dunne, Eileen F.
    Nielson, Carrie M.
    Stone, Katherine M.
    Markowitz, Lauri E.
    Giuliano, Anna R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (08) : 1044 - 1057
  • [12] Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
    Garland, Suzanne M.
    Hernandez-Avila, Mauricio
    Wheeler, Cosette M.
    Perez, Gonzalo
    Harper, Diane M.
    Leodolter, Sepp
    Tang, Grace W. K.
    Ferris, Daron G.
    Steben, Marc
    Bryan, Janine
    Taddeo, Frank J.
    Railkar, Radha
    Esser, Mark T.
    Sings, Heather L.
    Nelson, Micki
    Boslego, John
    Sattler, Carlos
    Barr, Eliav
    Koutsky, Laura A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) : 1928 - 1943
  • [13] Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
  • [14] Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    Harper, DM
    Franco, EL
    Wheeler, CM
    Moscicki, AB
    Romonowski, B
    Roteli-Martins, CM
    Jenkins, D
    Schuind, A
    Clemens, SAC
    Dubin, G
    [J]. LANCET, 2006, 367 (9518) : 1247 - 1255
  • [15] EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION
    KOUTSKY, LA
    GALLOWAY, DA
    HOLMES, KK
    [J]. EPIDEMIOLOGIC REVIEWS, 1988, 10 : 122 - 163
  • [16] Epidemiologic classification of human papillomavirus types associated with cervical cancer
    Muñoz, N
    Bosch, FX
    de Sanjosé, S
    Herrero, R
    Castellsagué, X
    Shah, KV
    Snijders, PJF
    Meijer, CJLM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) : 518 - 527
  • [17] Cost-effectiveness analyses of human papillomavirus vaccination
    Newall, Anthony T.
    Beutels, Philippe
    Wood, James G.
    Edmunds, W. John
    MacIntyre, C. Raina
    [J]. LANCET INFECTIOUS DISEASES, 2007, 7 (04) : 289 - 296
  • [18] Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
    Paavonen, Jorma
    Jenkins, David
    Bosch, F. Xavier
    Naud, Paulo
    Salmeron, Jorge
    Wheeler, Cosette M.
    Chow, Song-Nan
    Apter, Dan L.
    Kitchener, Henry C.
    Castellsague, Xavier
    de Carvalho, Newton S.
    Skinner, S. Rachel
    Harper, Diane M.
    Hedrick, James A.
    Jaisamrarn, Unnop
    Limson, Genara A. M.
    Dionne, Marc
    Quint, Wim
    Spiessens, Bart
    Peeters, Pascal
    Struyf, Frank
    Wieting, Susan L.
    Lehtinen, Matti O.
    Dubin, Gary
    [J]. LANCET, 2007, 369 (9580) : 2161 - 2170
  • [19] HPV infection in men
    Palefsky, Joel M.
    [J]. DISEASE MARKERS, 2007, 23 (04) : 261 - 272
  • [20] Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students
    Partridge, Jeffrey M.
    Hughes, James P.
    Feng, Qinghua
    Winer, Rachel L.
    Weaver, Bethany A.
    Xi, Long-Fu
    Stern, Michael E.
    Lee, Shu-Kuang
    O'Reilly, Sandra F.
    Hawes, Stephen E.
    Kiviat, Nancy B.
    Koutsky, Laura A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (08) : 1128 - 1136